Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 30, 2021
Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosisMasahiro Koh, Tsuyoshi Takahashi, Yukinori Kurokawa, et al.
Inflammatory Bowel Diseases|January 5, 2013
Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's diseaseShinichiro Shinzaki, Eri Kuroki, Hideki Iijima, et al.
Experimental Dermatology|April 19, 2012
Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblastsKanako Ontsuka, Yorihisa Kotobuki, Hiroshi Shiraishi, et al.
American Journal of Obstetrics and Gynecology|August 22, 2020
CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcomaRuriko Nakae, Shinya Matsuzaki, Satoshi Serada, et al.
Anticancer Research|May 29, 2023
Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 AntibodyYurina Saito, Tsuyoshi Takahashi, Kosuke Hiramatsu, et al.
International Journal of Cancer|February 25, 2017
Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft miceTakahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, et al.
International Journal of Cancer|May 30, 2013
New findings of kinase switching in gastrointestinal stromal tumor under imatinib using phosphoproteomic analysisTsuyoshi Takahashi, Satoshi Serada, Maiko Ako, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 8, 2025
Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cellsTakashi Yokouchi, Tsuyoshi Takahashi, Toshirou Nishida, et al.
International Journal of Cancer|February 8, 2023
Combination of pimitespib (TAS-116) with sunitinib is an effective therapy for imatinib-resistant gastrointestinal stromal tumorsRyugo Teranishi, Tsuyoshi Takahashi, Yuuki Obata, et al.
Pageof 18